Executive Profile

Stephen G. Dilly M.B.B.S, Ph.D. Chief Executive Officer, President and Director, APT Pharmaceuticals, Inc.

Age	Total Calculated Compensation	This person is connected to 5 Board Members in 5 different organizations across 4 different industries. See Board Relationships
52	--

Background

Dr. Stephen G. Dilly, M.B.B.S, Ph.D., has been the Chief Executive officer of PhotoThera, Inc. since January 2012 and serves as its President. Dr. Dilly is a Strategic Advisor and Member of Advisory Board at Physic Ventures, LLC. Dr. Dilly served as Chief Executive Officer at APT Pharmaceutical LLC. He was based in Foster City, California office of the firm and holds the position since September 2006. Dr. Dilly has extensive drug development experience. From October ... 2003 to April 2006, he served as the Senior Vice President, Head of Development, and Chief Medical Officer at Chiron Biopharmaceuticals in Emeryville, California, where Dr. Dilly was responsible for all clinical, regulatory, development and medical-marketing activities worldwide. Prior to joining APT, Dr. Dilly held a number of senior executive clinical, development and commercial support positions at leading pharmaceutical and biotechnology companies including Smithkline Beecham and Genentech, Inc. Prior to joining Chiron, he served as the Senior Vice President of Development Sciences and Chief Medical Officer and Head of Clinical, Head of Development Sciences, Vice President for Clinical R&D and Medical Affairs for Genentech in South San Francisco from September 1998 to September 2003. Dr. Dilly also held executive positions at Central Research in the United Kingdom, and was the Vice President of CardioPulmonary and Clinical Neuroscience at SmithKline Beecham in the United States and the United Kingdom. He has been a Director of Sangamo Biosciences Inc. since March 31,2010. He serves as a Director of PhotoThera, Inc. He has played important roles in the development and approval of numerous drugs including Kytril(R), Requip(R), Kredex(R), Paxil CR(R), Cathflo(R) Activase(R), Raptiva(R), Xolair(R), Avastin(R), Lucentis, Cubicin and Tarceva(R). Dr. Dilly has been a Director of Avigen Inc., since February 6, 2007. Dr. Dilly received a Ph.D. in Cardiac Physiology from University of London in 1988. He also holds an M.B.B.S. and a M.D. Dr. Dilly graduated as a physician from the University of London in 1982.

Corporate Headquarters 700 Airport Boulevard Burlingame, California 94010 United States Phone: 650-931-1666 Fax: 650-931-1667 Board Members Memberships Chief Executive Officer, President and Director PhotoThera, Inc. Chief Executive Officer, President and Director APT Pharmaceuticals, Inc. 2007-Present Director, Member of Compensation Committee and Member of Corporate Governance & Nominating Committee Avigen, Inc. 2010-Present Director and Member of Audit Committee Sangamo Biosciences Inc. Education Unknown/Other Education 1982 University Of London PhD 1988 University Of London Bachelor's Degree University Of London MD 1982 University Of London Other Affiliations Avigen, Inc. Genentech, Inc. Sangamo Biosciences Inc. PhotoThera, Inc. University Of London Physic Ventures, LLC

Annual Compensation There is no Annual Compensation data available. Stocks Options There is no Stock Options data available. Total Compensation There is no Total Compensation data available.

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.